Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Neoplasma ; 51(6): 460-4, 2004.
Article in English | MEDLINE | ID: mdl-15640956

ABSTRACT

Addition of antioxidants to chemotherapy is an unresolved problem in oncology. It is still an issue of debate, whether antioxidants may reduce rough cellular toxicity and thereby the systemic side effects of the chemotherapy, without sacrificing the anti-tumor efficacy. Gemcitabine is a rather new anti-cancer agent, which is quite potent against a range of drug resistant tumors, particularly breast cancer. Tumor-sensitivity towards gemcitabine can be increased with COX inhibitory anti-inflammatory agents and ribonucleotide reductase (RR) inhibitor flavopiridol. Acetaminophen and DMSO are two unique anti-inflammatory and anti- oxidant agents with unrelated structures, yet both capable to block RR and COX, simultaneously. Using plating efficacy and 3H- thymidine labeling, we monitored efficacy of acetaminophen and DMSO to modulate growth and gemcitabine sensitivity in FM3A breast tumor cells, which is highly used to study thymineless death induced by nucleotide-metabolism hemming drugs. Peculiarly, acetaminophen alone stimulated S-phase, which was not accompanied with enhanced plating, rather resulting in 40.3% growth inhibition at the 96 hour. DMSO alone significantly diminished both the plating and S-phase, which resulted in 71.7% growth inhibition at the 96 hour. Gemcitabine drastically reduced S-phase and plating until 72 hours, yet at 96 hours it lost its efficacy to suppress the S-phase with concomitant 2-fold rise in cell numbers in comparison to 72 hour time point. Both DMSO and acetaminophen brought S-phase to around zero percent in combination with gemcitabine until 48 hours, yet they both reduced early cytotoxicity of gemcitabine at the same time interval. However, at the 96 hour, they both strongly augmented gemcitabine efficacy to block S-phase and prevented the rise in plating. Acetaminophen and DMSO should be tested in animal models, whether they could augment efficacy and reduce the toxicity of gemcitabine.


Subject(s)
Acetaminophen/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Dimethyl Sulfoxide/pharmacology , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Cell Division/drug effects , Cyclooxygenase Inhibitors/pharmacology , Humans , Ribonucleotide Reductases/antagonists & inhibitors , S Phase/drug effects , Time Factors , Tumor Cells, Cultured , Gemcitabine
2.
Clin Imaging ; 25(3): 167-70, 2001.
Article in English | MEDLINE | ID: mdl-11679222

ABSTRACT

Malignant vagal paraganglioma is very uncommon and the diagnosis of malignancy is made on the basis of presence of distant metastasis rather than the histological findings. We report angiography findings of metastatic cervical lymph nodes in a case of malignant vagal paraganglioma.


Subject(s)
Aortic Bodies/diagnostic imaging , Cerebral Angiography , Glomus Tumor/diagnostic imaging , Adult , Angiography, Digital Subtraction , Aortic Bodies/pathology , Aortic Bodies/surgery , Diagnosis, Differential , Female , Glomus Tumor/pathology , Glomus Tumor/surgery , Humans , Lymphatic Metastasis , Magnetic Resonance Imaging
3.
Pediatr Hematol Oncol ; 18(2): 147-52, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11255734

ABSTRACT

Osteosarcoma of the cranial facial region is uncommon and only rarely involves the ethmoid or sphenoid bones. The authors report on an unusual case of a 17-year-old male presenting with chondroblastic osteosarcoma of the maxillary, ethmoid, and sphenoid sinuses who remains well and disease-free at 46 months. He was treated with anterior craniofacial resection followed by postoperative radiotherapy to the sight of the primary tumor. He did not receive chemotherapy because of emerging hepatitis-B infection and vasculitis. The literature on extragnathic craniofacial osteosarcomas is reviewed with particular emphasis on treatment options of this rare tumor.


Subject(s)
Osteosarcoma/therapy , Skull Neoplasms/therapy , Adolescent , Chondrocytes/pathology , Disease-Free Survival , Ethmoid Sinus/pathology , Ethmoid Sinus/surgery , Humans , Magnetic Resonance Imaging , Male , Maxillary Sinus Neoplasms/radiotherapy , Maxillary Sinus Neoplasms/surgery , Maxillary Sinus Neoplasms/therapy , Osteosarcoma/radiotherapy , Osteosarcoma/surgery , Skull Neoplasms/radiotherapy , Skull Neoplasms/surgery , Sphenoid Sinus/pathology , Sphenoid Sinus/surgery , Tomography, X-Ray Computed
4.
Auris Nasus Larynx ; 28(1): 9-14, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11137357

ABSTRACT

OBJECTIVE: To evaluate Cisplatin (CP) induced ototoxicity and the effects of vitamin B treatment on ototoxicity in guinea pigs by using the Transient Evoked Otoacoustic Emission (TEOAE) technique. METHODS: Eleven guinea pigs were divided into two groups and they were tested by TEOAE before and after the experiment. A TEOAE response was regarded as positive when all of the following criteria were met: 1. The mean amplitude of the cochlear response in dB pe SPL should be greater than that of the noise in the external auditory canal; 2. The reproducibility rate of the response should be greater than 50%; 3. The stimulus stability rate should be greater than 65%; 4. The signal to noise ratio of the response in 1, 2, 3, 4 and 5 kHz band frequencies should be greater than 3 dB pe SPL in at least two bands. The first group included five animals that had only CP injections. Six animals in the second group received additional 0.2 ml/kg combined vitamin B preparations for 7 consecutive days. Thereafter, the right and left ears of all animals in both groups were tested by TEOAE. RESULTS: TEOAE responses recorded from 22 ears of 11 guinea pigs before drug administrations showed that the responses with maximum amplitude were originated from the mid-frequency region. Positive TEOAE responses were significantly reduced after CP administrations in both groups when compared with their respective pretreatment results (P<0.01). However, vitamin B injections, in addition to a single large dose of CP, resulted in significantly better TEOAE responses than those obtained after only CP injections (P<0.05). CONCLUSIONS: The routine use of TEOAE monitoring is recommended in clinical CP treatment protocols for the early detection and follow up of ototoxicity. Also, prospective clinical trials are needed in order to validate the protective effects of vitamin B treatment against ototoxicity.


Subject(s)
Antineoplastic Agents/toxicity , Cisplatin/toxicity , Cochlea/drug effects , Hearing Loss, Sensorineural/chemically induced , Hearing Loss, Sensorineural/prevention & control , Otoacoustic Emissions, Spontaneous/physiology , Vitamin B Complex/therapeutic use , Acoustic Stimulation/methods , Animals , Cochlea/physiopathology , Electric Stimulation/methods , Guinea Pigs , Hearing Loss, Sensorineural/physiopathology
5.
Postgrad Med J ; 74(872): 363-4, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9799894

ABSTRACT

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.


Subject(s)
Etidronic Acid/adverse effects , Hearing Loss, Sensorineural/etiology , Osteoporosis, Postmenopausal/drug therapy , Aged , Etidronic Acid/therapeutic use , Female , Follow-Up Studies , Hearing Loss, Sensorineural/chemically induced , Humans , Otosclerosis/complications
6.
Ann Otol Rhinol Laryngol ; 105(8): 659-64, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8712639

ABSTRACT

Otosclerotic cochlear involvement is a rather frequent disease that has not been clearly understood in terms of diagnosis and management. Objective evaluation methods are needed to confirm the clinical diagnosis, investigate the relationship with hearing impairment, and validate the results of treatment. In this study two ear groups with bone conduction hearing loss (BCHL) were investigated with audiometry and high-resolution computed tomography (HRCT). In the first group (n = 22) the diagnosis of fenestral otosclerosis was confirmed at operation; the second group (n = 9) was composed of ears clinically suspicious for purely cochlear involvement. Additionally, a control group (n = 14) of otologically normal ears was also studied. Foci of demineralization were demonstrated in 58% of the ears in the two groups; the sensorineural hearing loss (SNHL) in those ears was significantly worse than in those with normal radiologic findings. Three methods of HRCT densitometry were used to determine the abnormal regions in the cochlear capsule; the results suggested that hypodense regions were consistent with a greater degree of SNHL, in contrast to the hyperdense ones in ears with better cochlear reserves. Agreement was found between the location of the density change and the frequency topography of the SNHL; densitometric values were correlated with the bone conduction thresholds for certain frequencies. It is concluded that the spongiotic foci are responsible for the SNHL, since there was a correlation between their location and the SNHL frequency. The determination of better hearing in those ears with sclerotic foci supports the hypothesis that the sclerotic phase may not be a healing process following the spongiotic phase, and that it can be the first stage of the disease.


Subject(s)
Cochlea/physiopathology , Densitometry , Hearing Loss, Sensorineural/etiology , Otosclerosis , Tomography, X-Ray Computed , Humans , Otosclerosis/complications , Otosclerosis/diagnosis , Otosclerosis/physiopathology
7.
Urology ; 46(3): 406-7, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7544935

ABSTRACT

Metastasis of prostate cancer to the parotid gland is exceedingly rare, with only 4 cases reported in the literature. We present the case of an 83-year-old white man who had a painless parotid mass that was diagnosed as metastatic prostate cancer. Immunohistochemical staining with prostate-specific antigen was positive. This is the first case of prostate cancer presenting with a painless parotid mass. Prostate cancer can be metastatic to the head and neck region, and this should be kept in mind when treating patients with this disease.


Subject(s)
Adenocarcinoma/secondary , Parotid Neoplasms/secondary , Prostatic Neoplasms/pathology , Adenocarcinoma/diagnosis , Aged , Aged, 80 and over , Biopsy, Needle , Bone Neoplasms/secondary , Humans , Male , Parotid Neoplasms/diagnosis , Prostate-Specific Antigen/analysis , Prostatic Neoplasms/diagnosis , Tomography, X-Ray Computed
8.
J Laryngol Otol ; 108(9): 795-7, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7964149

ABSTRACT

Parapharyngeal space cysts, besides salivary gland origin may be derived from the first and dorsal portions of the second pharyngeal pouches. They are mucosal or epithelial lined structures with no external or visceral opening and always present on the lateral aspects of the nasopharyngeal wall. Two consecutive cases of parapharyngeal space cysts totally excised by transoral and transparotid routes are presented.


Subject(s)
Branchioma/diagnostic imaging , Head and Neck Neoplasms/diagnostic imaging , Adult , Branchioma/surgery , Female , Head and Neck Neoplasms/surgery , Humans , Male , Middle Aged , Postoperative Period , Tomography, X-Ray Computed
9.
J Laryngol Otol ; 105(11): 954-6, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1761953

ABSTRACT

Carcinomas of the sebaceous glands of the skin are uncommon. These tumours metastasize frequently. A case of cutaneous sebaceous carcinoma localized in the postauricular region is presented with its exceptional large size and very poor prognosis.


Subject(s)
Adenocarcinoma/pathology , Head and Neck Neoplasms/pathology , Sebaceous Gland Neoplasms/pathology , Aged , Humans , Male
10.
J Laryngol Otol ; 105(6): 493-5, 1991 Jun.
Article in English | MEDLINE | ID: mdl-2072027

ABSTRACT

Lingual thyroid is an uncommon developmental aberration of embryogenesis. It may present as a mid-line, non-tender, painless, reddish appearing swelling in the throat. Magnetic resonance imaging (MRI) is a relatively new diagnostic method for this condition. Two cases of lingual thyroid are reviewed with their MRI's and surgical results.


Subject(s)
Choristoma/diagnosis , Thyroid Gland , Tongue Neoplasms/diagnosis , Adolescent , Child , Choristoma/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Male , Radionuclide Imaging , Tongue/diagnostic imaging , Tongue Neoplasms/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...